Dialysis Training Therapy: The DiaTT Trial

NCT ID: NCT03885102

Last Updated: 2022-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1211 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-01

Study Completion Date

2022-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

DiaTT is an interventional, cluster-randomized (1:1), multicenter trial for patients with chronic kidney disease undergoing hemodialysis (n=1,100). This trial will test the effectiveness (by change of sit-to-stand test between baseline and 12 months) of intradialytic exercise training (ET) and health literacy counseling (HLC) for 12 months (Intervention group) in comparison to control group (usual care, UC; no ET, no HLC).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of this trial is to assess the effectiveness of intradialytic exercise training (ET) and health literacy counselling (HLC) over 12 months intervention in patients undergoing chronic outpatient hemodialysis as compared to usual care (UC). The primary endpoint is change in Sit-to-Stand (STS60) test, from baseline to after 12 months intervention. The ET consists of both resistance and endurance training, focusing on improving patients' health status and physical functioning. Health literacy counseling aims at improving education, proficiency and self-awareness of the patient.

All patients undergoing hemodialysis in participating centers (clusters) for at least four weeks are eligible to participate in the study. Irrespective of randomized center (cluster) group assignment, all dialysis and overall medical treatments will remain unchanged and follow standard of care and center routine without adaptations to the training intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Diseases Hemodialysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Random assignment in 1:1 ratio into either intervention group (12 months intradialytic exercise intervention; 50% aerobic exercise, 50% resistance training; thrice a week for 60 min per dialysis session) and health literacy counselling (HLC) or control group/usual care (Usual care without any exercise intervention or HLC)
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

12 months intradialytic exercise intervention

Group Type EXPERIMENTAL

Intradialytic exercise intervention

Intervention Type BEHAVIORAL

50% aerobic exercise, 50% resistance training thrice a week for 60 min per dialysis session, and health literacy counselling

Usual care

Usual care according to current guidelines

Group Type ACTIVE_COMPARATOR

Usual Care

Intervention Type BEHAVIORAL

Usual care with no exercise intervention or health literacy counselling

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intradialytic exercise intervention

50% aerobic exercise, 50% resistance training thrice a week for 60 min per dialysis session, and health literacy counselling

Intervention Type BEHAVIORAL

Usual Care

Usual care with no exercise intervention or health literacy counselling

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients ≥ 18 years of age
* chronic ambulatory hemodialysis for \> 4 weeks
* Written and signed confirmation by the treating dialysis physician that the patient is able to exercise
* signed informed consent to participation in QiN registry
* signed informed consent obtained according to confidentiality and data protection regulation, international guidelines and local laws

Exclusion Criteria

* Unstable angina pectoris
* Uncontrolled arterial hypertension (systolic blood pressure \> 180 mmHg or diastolic BP \> 105 mmHg on repeated measurements)
* Uncontrolled tachycardia
* Acute severe infection
* Planned live kidney transplantation within the next 12 months
* Planned conversion to home-hemodialysis or peritoneal dialysis within the next 12 months
* Dialyzing in long overnight dialysis shift
* Participation in a regular exercise program during hemodialysis sessions (≥ 1/week) in the last 6 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Technical University of Munich

OTHER

Sponsor Role collaborator

University Hospital of Cologne

OTHER

Sponsor Role collaborator

KfH Kuratorium für Dialyse und Nierentransplantation

UNKNOWN

Sponsor Role collaborator

Clinical Trials Unit Freiburg

OTHER

Sponsor Role collaborator

AOK PLUS

INDUSTRY

Sponsor Role collaborator

BARMER

OTHER

Sponsor Role collaborator

Techniker Krankenkasse

OTHER

Sponsor Role collaborator

Federal Joint Committee

OTHER_GOV

Sponsor Role collaborator

Prof. Dr. med. Martin Halle

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Dr. med. Martin Halle

Univ.-Prof. MD

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gabriele Ihorst, PhD

Role: STUDY_CHAIR

Clinical Trials Unit Freiburg, Medical Center, University of Freiburg

Gero von Gersdorff, MD

Role: STUDY_CHAIR

Department II of Internal Medicine, University of Cologne

Kirsten Anding-Rost, MD

Role: STUDY_CHAIR

KfH Kuratorium für Dialyse und Nierentransplantation e.V.

Martin Halle, Prof. MD

Role: PRINCIPAL_INVESTIGATOR

Department of Prevention, Rehabilitation and Sports medicine, University hospital 'Klinikum rechts der Isar', Technical University of Munich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

KfH-Nierenzentrum

Amberg, Bavaria, Germany

Site Status

KfH-Nierenzentrum

Aschaffenburg, Bavaria, Germany

Site Status

KfH-Nierenzentrum

Bamberg, Bavaria, Germany

Site Status

KfH-Nierenzentrum

Coburg, Bavaria, Germany

Site Status

KfH-Nierenzentrum

Dachau, Bavaria, Germany

Site Status

KfH-Nierenzentrum

Ebersberg, Bavaria, Germany

Site Status

KfH-Nierenzentrum

Freising, Bavaria, Germany

Site Status

KfH-Nierenzentrum

Fürstenzell, Bavaria, Germany

Site Status

KfH-Nierenzentrum

Fürth, Bavaria, Germany

Site Status

KfH-Nierenzentrum

München, Bavaria, Germany

Site Status

KfH-Nierenzentrum

Straubing, Bavaria, Germany

Site Status

KfH-Nierenzentrum

Aachen, Northrhine, Germany

Site Status

KfH-Nierenzentrum

Bergisch Gladbach, Northrhine, Germany

Site Status

KfH-Nierenzentrum

Cologne, Northrhine, Germany

Site Status

KfH-Nierenzentrum

Halle, Saxony-Anhalt, Germany

Site Status

KfH-Nierenzentrum

Magdeburg, Saxony-Anhalt, Germany

Site Status

KfH-Nierenzentrum

Jena, Thuringia, Germany

Site Status

KfH-Nierenzentrum

Sonneberg, Thuringia, Germany

Site Status

KfH-Nierenzentrum

Bochum, Westphalia, Germany

Site Status

KfH-Nierenzentrum

Hagen, Westphalia, Germany

Site Status

KfH-Nierenzentrum

Marl, Westphalia, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

von Gersdorff G, von Korn P, Duvinage A, Ihorst G, Josef A, Kaufmann M, Baer T, Fellerhoff T, Fuhrmann I, Koesel E, Zeissler S, Bobka L, Heinrich M, Schindler A, Weber R, Breuer C, Meyer AM, Polidori MC, Dinges SMT, Schoenfeld J, Siebenbuerger M, Degenhardt S, Anding-Rost K, Halle M. Cluster Randomized Controlled Trial on the Effects of 12 Months of Combined Exercise Training during Hemodialysis in Patients with Chronic Kidney Disease-Study Protocol of the Dialysis Training Therapy (DiaTT) Trial. Methods Protoc. 2021 Aug 31;4(3):60. doi: 10.3390/mps4030060.

Reference Type RESULT
PMID: 34564306 (View on PubMed)

Anding-Rost K, von Gersdorff G, von Korn P, Ihorst G, Josef A, Kaufmann M, Huber M, Bar T, Zeissler S, Hofling S, Breuer C, Gartner N, Haykowsky MJ, Degenhardt S, Wanner C, Halle M. Exercise during Hemodialysis in Patients with Chronic Kidney Failure. NEJM Evid. 2023 Sep;2(9):EVIDoa2300057. doi: 10.1056/EVIDoa2300057. Epub 2023 Jun 17.

Reference Type DERIVED
PMID: 38320198 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

509/18S-KK

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Telerehabilitation in Hemodialysis Patients.
NCT06891482 ENROLLING_BY_INVITATION NA